{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T11:36:49Z","timestamp":1778672209397,"version":"3.51.4"},"reference-count":12,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1097\/mph.0b013e31816624a4","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T19:17:05Z","timestamp":1236280625000},"page":"519-521","source":"Crossref","is-referenced-by-count":29,"title":["Severe Neurotoxicities in a Case of Charcot-Marie-Tooth Disease Type 2 Caused by Vincristine for Acute Lymphoblastic Leukemia"],"prefix":"10.1097","volume":"30","author":[{"given":"Takuro","family":"Nishikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Kawakami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Kumamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiro","family":"Tonooka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Hayasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Okamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Kawano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-5-20210227","first-page":"1894","article-title":"Pediatric Neurology. 4th ed","author":"Smith","year":"2006"},{"key":"R2-5-20210227","first-page":"2076","article-title":"Textbook of Pediatrics. 17th ed","author":"Sarnat","year":"2004"},{"key":"R3-5-20210227","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ncpneuro0071","article-title":"Mechanisms of disease: a molecular genetic update on hereditary axonal neuropathies","volume":"2","author":"Zuchner","year":"2006","journal-title":"Nat Clin Pract Neurol"},{"key":"R4-5-20210227","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.gim.0000200160.29385.73","article-title":"Charcot-Marie-Tooth disease and related hereditary polyneuropathies: molecular diagnostics determine aspects of medical management","volume":"8","author":"Szigeti","year":"2006","journal-title":"Genet Med"},{"key":"R5-5-20210227","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/(SICI)1097-0142(19960401)77:7<1356::AID-CNCR20>3.0.CO;2-#","article-title":"Severe vincristine neuropathy in Charcot-Marie-Tooth disease type1A","volume":"77","author":"Graf","year":"1996","journal-title":"Cancer"},{"key":"R6-5-20210227","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/mpo.2950250212","article-title":"Vincristine neuropathy in type 1 and type 2 Charcot-Marie-Tooth disease (hereditary motor sensory neuropathy)","volume":"25","author":"Igarashi","year":"1995","journal-title":"Med Pediatr Oncol"},{"key":"R7-5-20210227","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/00043426-200304000-00010","article-title":"Vincristine-induced neuropathy as the initial presentation of Charcot-Marie-Tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study","volume":"25","author":"Chauvenet","year":"2003","journal-title":"J Pediatr Hematol Oncol"},{"key":"R8-5-20210227","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/jmg.17.5.329","article-title":"Genetic aspects of hereditary motor and sensory neuropathy (types1 and 2)","volume":"17","author":"Harding","year":"1980","journal-title":"J Med Genet"},{"key":"R9-5-20210227","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1651-2227.2003.tb02505.x","article-title":"Vincristine in childhood leukaemia: no pharmacokinetic rationale for dose reduction in adolescents","volume":"92","author":"Frost","year":"2003","journal-title":"Acta Pediatr"},{"key":"R10-5-20210227","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/01.mph.0000172751.06286.5b","article-title":"Itraconazole-related increased vincristine neurotoxicity: case report and review of literature","volume":"27","author":"Bermudez","year":"2005","journal-title":"J Pediatr Hematl Oncol"},{"key":"R11-5-20210227","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1056\/NEJM197206222862523","article-title":"Vincristine neurotoxicity","volume":"286","author":"Weiden","year":"1972","journal-title":"N Engl J Med"},{"key":"R12-5-20210227","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jns.2005.11.014","article-title":"Medication-induced exacerbation of neuropathy in Charcot Marie Tooth disease","volume":"15","author":"Weimer","year":"2006","journal-title":"J Neurol Sci"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0b013e31816624a4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:02:51Z","timestamp":1620964971000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00043426-200807000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e31816624a4","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}